Now that the selection has been made, the next bidding process goes quickly.

Three days later, the bidding conference was successfully held.

The major pharmaceutical companies have already inquired about the news from their own channels in advance.

They all submitted the bids tacitly, and then quietly waited for the final result.

But they did not return empty-handed. Instead, they signed another contract with Sanqing, and sold all the discarded prescriptions they brought with them at a discounted price.

There are not many discarded prescriptions in each company. Domestic pharmaceutical companies generally have about five or six prescriptions, and multinational giants only have a dozen. Most of them have been carefully selected by them, and they can no longer squeeze out any potential prescriptions.

The research and development level of domestic companies is generally relatively low, lagging behind overseas by nearly 20 years, and there are very few new drugs in the discarded prescriptions, most of which are improved prescriptions.

They are very self-aware, and they charged a friendship price of one million, mainly because they wanted to make good deals with Sanqing, so that they could cooperate in the domestic market in the future.

After all, in this bidding, everyone knows that the protagonist must be a foreign pharmaceutical company, and the primary goal of Sanqing is to sell overseas licenses to earn money and recover costs as soon as possible.

When Sanqing starts to develop the domestic market, it might not be possible to talk about mutual authorization and cooperation.

After all, Sanqing only has anti-cancer drugs to emerge, and it is still inferior to some powerful domestic pharmaceutical companies in other fields.

Mutual authorization and cooperation between pharmaceutical companies is very common, especially domestic pharmaceutical companies, each has its own specialization direction, and complement each other, so that they can continuously expand the market and enhance their own strength.

The multinational giants have also packaged and sold the discarded prescriptions to Sanqing. Their research and development capabilities are all top in the world, and they are more confident in their discarded prescriptions. They all firmly believe that with Sanqing’s research and development level, it is absolutely impossible to find other applications from them. direction.

In short, Wei Kang's warehouse of discarded prescriptions is already full and full.

A few days later, the conference hall of Sanqing Pharmaceutical was refurbished.

A red banner hung high, reading "Signing Ceremony of Sanqing Pharmaceutical and Pfizer's Overseas Authorized Cooperation".

Wei Kang signed the contract with the CEO of Pfizer, who arrived on a special trip. The two sides exchanged signatures and took pictures.

The flashlights of the media reporters kept flashing to capture this historic event.

Gao Tuoyu, the main leader of the municipal level, was also present. This time, Bureau Xie of the Municipal Food and Drug Administration could only obediently stay aside and stand with Andre.

Originally, such a large cooperation project alarmed the provincial leaders, but the time was short, so only the municipal leaders came, but they brought the kind care of the provincial leaders to show how much they valued it.

Gao Tuoyu shook hands with Wei Kang cordially, and his smile was extraordinarily amiable: "Mr. Wei, Sanqing Pharmaceutical has not only brought glory to the city, but also attracted the attention of the province. Recently, the city is responding to the call of the state to actively support the development of high-tech enterprises. You really brought us a big surprise."

"And this project is also very important, 3 billion US dollars, more than 20 billion US dollars just got it."

Wei Kang smiled and said: "I still want to thank the leaders for their support. Besides, there are not so many after tax."

Gao Tuoyu laughed, looked to the left and right and said, "Mr. Wei is indeed a people's entrepreneur. He was the first one to think about paying taxes after signing a big contract."

The leaders on the left and right also laughed appreciatively.

Gao Tuoyu patted Wei Kang on the shoulder and said with a smile: "Okay, then I will tell you another piece of good news. Last week, the Xie Bureau of the Food and Drug Administration has helped you apply for the annual project of the national major new drug creation project. Now it is estimated that it has reached the General Administration. There, I don't think it's a big problem."

"As long as you pass it, you can get a series of tax-free preferential policies this year, as well as provincial project funding. For those who complete the clinical phase I, II, and III studies of new drugs, they will be given up to 1 million yuan and 2 million yuan respectively." and 3 million yuan in funding."

"Although Mr. Wei is rich and powerful now, he may not need this subsidy very much, but this tax-free preferential policy is still very strong, and it must satisfy Mr. Wei."

Then he said with great concern: "Mr. Wei, the province attaches great importance to and supports you Sanqing Pharmaceutical. Don't move the company's headquarters."

"Now that you have abundant funds, you definitely need to renovate and expand production. We still have abundant land resources in Kunming City, and the price is also very favorable. I think there are several suitable land in the industrial park not far from you. If Mr. Wei needs industrial You can boldly mention the land use.”

When Sanqing Pharmaceutical's new drug is put into production, it will continue to receive tax revenue and drive local employment. It will grow stronger in the future, and it will even drive the development of Kunming's pharmaceutical industry. These are the things that Gao Tuoyu attaches great importance to.

After all, Kunming City is only a small third- and fourth-tier city, and it is not as good as the nearby first- and second-tier cities in all aspects. He is also afraid that Wei Kang will move his headquarters to Haishi or Suzhou City, so he will naturally try to win over Sanqing, the egg-laying city. The hen is firmly tied to the development train of Kunming City.

Wei Kang smiled and nodded, circling among the crowd.

3 billion US dollars is indeed a large amount, but according to the agreement, the payment will be divided into three installments, an advance payment of 500 million, and a milestone payment of 2.5 billion after registration and sales.

So in fact, he only got 500 million U.S. dollars at the beginning, and at least he won't get the follow-up payment until Eagle Country's FDA registration is successful.

If there is any serious adverse reaction in the follow-up clinical trial, which makes it impossible to pass the strict requirements of the FDA, then not only will the subsequent money be lost, but all the previous payment will also be returned.

This is an insurance that Pfizer has added to itself. After all, it is not long before the new drug is clinically available, and they are not completely relieved.

Wei Kang agreed to Pfizer's request because he could guarantee that the drug would never have any serious adverse reactions.

Representatives of other pharmaceutical companies at the scene also looked at the CEOs of Weikang and Pfizer with envy.

The US$3 billion overseas licensing cooperation agreement is just the beginning.

It should be the largest amount of authorized cooperation in China so far.

They also want such sky-high licensing cooperation.

Whether it is licensing out or buying licenses, people are envious and jealous.

Pfizer is fine, after all, it is a multinational giant.

But Wei Kang is just a young man in his twenties.

In the blink of an eye, he was worth tens of billions.

From a small boss of a pharmaceutical company on the verge of bankruptcy, he counterattacked and became a rich man in an instant.

Just one cancer-fighting prescription inspired by an abandoned prescription.

Simply legendary.

It's as legendary as Pfizer's Aiwanke.

Moreover, Weikang is the sole major shareholder of Sanqing Pharmaceutical.

Although this worth is still far from the position of the richest man in pharmaceutical companies.

But this is pure cash flow, which is much stronger than many listed companies that are insolvent and have profits of only tens of millions.

Not to mention, there will be a lot of money after the anticancer drug is put into production.

I believe that within a few years, Wei Kang will appear on the domestic wealth list.

Everyone in the media was as excited as a chicken blood, they chased and intercepted Wei Kang, and kept asking questions.

Mr. Wei, were you good at school when you were young?

Mr. Wei, did you win any awards in middle school?

Mr. Wei, talk about your college days. Did you study hard all day long?

Mr. Wei, are you single now? How many girlfriends have you had?

Mr. Wei, how did the death of your parents affect you?

When Wei Kang heard the last question, his face turned dark, and he secretly wrote down this reporter in his notebook.

Such an uninformed media must be blocked and never see him again.